Adjuvant Radiation for Rectal Cancer: Do We Measure Up to the Standard of Care? An Epidemiologic Analysis of Trends Over 25 Years in the United States
- 1 January 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 48 (1) , 9-15
- https://doi.org/10.1007/s10350-004-0792-8
Abstract
PURPOSE:In the United States, adjuvant radiation therapy is currently recommended for most patients with rectal cancer. We conducted this population-based study to evaluate the rate of radiation therapy and the factors affecting its delivery.METHODS:We used the Surveillance Epidemiology and End ResuKeywords
This publication has 20 references indexed in Scilit:
- Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trialsThe Lancet, 2001
- Who Gets Adjuvant Treatment for Stage II and III Rectal Cancer? Insight From Surveillance, Epidemiology, and End Results–MedicareJournal of Clinical Oncology, 2001
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerNew England Journal of Medicine, 2001
- Effect of a surgical training programme on outcome of rectal cancer in the County of StockholmThe Lancet, 2000
- Randomized Trial of Postoperative Adjuvant Chemotherapy With or Without Radiotherapy for Carcinoma of the Rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02JNCI Journal of the National Cancer Institute, 2000
- Mesorectal excision for rectal cancer: A view from EuropeSeminars in Surgical Oncology, 1998
- Influence of surgery on metachronous distant metastases and survival in rectal cancer.Journal of Clinical Oncology, 1998
- Improved Survival with Preoperative Radiotherapy in Resectable Rectal CancerNew England Journal of Medicine, 1997
- Analysis of local recurrence rates after surgery alone for rectal cancerInternational Journal of Colorectal Disease, 1995
- Adjuvant Therapy for Patients With Colon and Rectal CancerJAMA, 1990